VEGFA and lung carcinoma: Supporting this fact, a recent study reported that immune complexes led to chronic inflammation (endothelial cells activation) in modality therapy and in tumour cell lysate (TCL) from lung cancer in murine models, resulting in pro-tumour effects by complement activation and increment of angiogenesis via VEGF production by activated macrophages thereby promoting tumour growth and spread.